The present study aimed to investigate the comparative evaluation of pharmacological efficacy between
sulfasalazine alone and
sulfasalazine in combination with herbal medicine on
dextran sodium sulfate- (DSS-) induced UC in mice. Balb/c mice received 5% DSS in
drinking water for 7 days to induce
colitis. Animals were divided into five groups (n = 9): Group I (normal group), Group II (DSS control group), Group III (DSS +
sulfasalazine (30 mg/kg)), Group IV (DSS +
sulfasalazine (60 mg/kg)), and Group V (DSS +
sulfasalazine (30 mg/kg) + Cinnamomi Cortex and Bupleuri Radix mixture (30 mg/kg) (SCB)). Colonic pathological changes were analyzed using hematoxyline/
eosin staining. The
antioxidant, inflammatory, and apoptotic
protein levels were determined using western blotting. SCB supplementation, as well as
sulfasalazine, suppressed colonic length and mucosal inflammatory infiltration. In addition, SCB treatment significantly reduced the expression of proinflammatory signaling molecules through suppression of both
mitogen-activated protein kinases (MAPK) and
nuclear factor-kappa B (NF-κB) signaling pathways and prevented the apoptosis of the colon. Moreover, SCB administration significantly led to the upregulation of
antioxidant enzymes including SOD and
catalase. Taken together, SCB treatment might offer a better treatment for human UC than
sulfasalazine alone or may be useful as an alternative therapeutic strategy against UC, without any evidence of side effects.